MENS

Conviction 20HealthcareScan · Thu, Jun 25, 2026

Inverted hammer

MENS$1.87+7.47%

ResistanceSupportVol 14

Vol MA14 183.63K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Jyong Biotech Ltd.Biotechnologywww.healtheverbiotech.com ↗

Price1.87

Change+7.47%

Gap+3.45%

Rel volume2.58×

Avg volume147.42K

Avg $ vol258.27K

SMA 201.84

SMA 502.05

SMA 20017.17

Price vs 50-8.62%

Price vs 200-89.11%

MA stackbearish

50/200 cross—

Supertrenddown · 2.09

RSI (14)50

MACD hist0.01

MACD crossbull · 0d

Stoch %K / %D58 / 37

ADX (14)26

+DI / −DI25 / 17

RSI divergence—

MACD divergence—

ATR %+9.67%

ADR %10.28%

52w high65.62

52w low1.46

From 52w high-97.15%

Above 52w low+28.08%

New 52w highNo

SqueezeOff

Bollinger width50.89%

%B0.53

Donchian pos47.45%

Donchian high2.28

Donchian low1.50

AVWAP (52w high)15.09

vs AVWAP high-87.61%

AVWAP (52w low)2.09

vs AVWAP low-10.37%

OBV trendFlat

Chaikin MF (20)-0.23

Today vs 20d2.58×

Avg vol (14d)183.63K

Avg vol (20d)147.42K

Avg $ vol (20d)258.27K

Market cap142.17M

RS 3m (vs SPY)-25.26%

RS 6m (vs SPY)-52.93%

RS line new highNo

Trend template0/8

Technical rank14.3

1 week+16.88%

1 month-13.82%

3 months-10.53%

6 months-60.88%

1 year-77.17%

YTD-45.16%

P/E—

P/B-5.71

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq-0.70

Current0.45

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value158.45M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out76.03M

Employees27

ListedTue, Jun 17, 2025

Free float31.08M

Float %40.9%

Short interest249.73K

Days to cover5.6d

Short volume43.2%

Squeeze score44 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank14.3 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Congress activity

Disclosed STOCK Act trades in MENS

All disclosures →

No recent disclosed trades by Congress in MENS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MENS

No recent insider (Form 4) filings in MENS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in MENS

EDGAR →

No recent SEC filings on file for MENS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.